ArTS Archivio della ricerca di Trieste

SOBHANI, NAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.417
EU - Europa 1.595
AS - Asia 609
SA - Sud America 11
OC - Oceania 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.639
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.404
PL - Polonia 796
IT - Italia 307
SE - Svezia 205
CN - Cina 198
SG - Singapore 191
HK - Hong Kong 126
IE - Irlanda 87
DE - Germania 53
UA - Ucraina 27
BG - Bulgaria 24
FI - Finlandia 23
VN - Vietnam 22
TR - Turchia 20
GB - Regno Unito 19
MY - Malesia 16
BE - Belgio 11
IN - India 10
BR - Brasile 9
CA - Canada 9
NL - Olanda 8
JP - Giappone 7
IR - Iran 6
CH - Svizzera 5
KR - Corea 5
AT - Austria 4
CZ - Repubblica Ceca 4
ES - Italia 4
MX - Messico 4
FR - Francia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RO - Romania 3
AR - Argentina 2
ID - Indonesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
CI - Costa d'Avorio 1
GR - Grecia 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
NP - Nepal 1
RS - Serbia 1
RU - Federazione Russa 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
WS - Samoa 1
Totale 4.639
Salva come PNG Salva come JPEG
Città #
Warsaw 796
Fairfield 354
Chandler 214
Ashburn 198
Houston 195
Singapore 173
Woodbridge 173
Seattle 135
Hong Kong 124
Ann Arbor 118
Trieste 118
Cambridge 115
Wilmington 107
Menlo Park 88
Boardman 61
Columbus 59
Princeton 49
Beijing 44
Santa Clara 42
Jacksonville 37
Dublin 27
Sofia 24
Dearborn 22
Dong Ket 22
Redwood City 19
Bremen 17
Helsinki 17
Izmir 17
San Diego 16
Duino-Aurisina 14
Montegaldella 11
Brussels 9
Milan 9
Nanjing 8
Tianjin 8
Udine 8
Decatur 7
Eagan 7
Munich 7
Redmond 7
Shanghai 7
Kunming 6
Norwalk 6
Phoenix 6
Dongguan 5
Guangzhou 5
Hefei 5
London 5
Padova 5
Cagliari 4
Fremont 4
Frosinone 4
Fuzhou 4
Hangzhou 4
Kherson 4
Shenyang 4
Tehran 4
Toronto 4
Auckland 3
Bloomsbury 3
Boydton 3
Buffalo 3
Capriate San Gervasio 3
Changsha 3
Chisinau 3
Dallas 3
Durham 3
Florence 3
Jinan 3
Kocaeli 3
Lagonegro 3
Lappeenranta 3
Los Angeles 3
Mountain View 3
Mumbai 3
Nanchang 3
New York 3
Savignano sul Panaro 3
Taiyuan 3
Taizhou 3
Tokyo 3
Vienna 3
Zamboanga City 3
Zhengzhou 3
Alpharetta 2
Atlanta 2
Aurora 2
Beinasco 2
Bern 2
Bethesda 2
Buenos Aires 2
Clarkesville 2
Cordenons 2
Deventer 2
Eberbach 2
Falls Church 2
Ferrara 2
Frankenthal 2
Hebei 2
Huixquilucan de Degollado 2
Totale 3.672
Salva come PNG Salva come JPEG
Nome #
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 373
The predictive role of the immune system for response to therapy and survival in patients with solid tumors. 331
Advances in systemic therapy for metastatic breast cancer: future perspectives 322
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 316
Bevacizumab in small cell lung cancer 282
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 260
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 260
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 242
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 237
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 205
Advances in systemic therapy for malignant mesothelioma: Future perspectives 175
PROGNOSTIC ROLE OF TUMOR INFILTRATING LYMPHOCITES (TILS) IN EPITHELIOID PLEURAL MESOTHELIOMA 170
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 169
Corticosteroid switch after progression on abiraterone acetate plus prednisone 160
Lenvatinib for the treatment of renal cell carcinoma 137
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 135
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 122
Avelumab in gastric cancer 76
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 72
Mutant p53 as an antigen in cancer immunotherapy 71
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses 67
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 64
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy 64
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer 59
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair 54
Early changes of the standardized uptake values (SUVmax) predict the efficacy of everolimus-exemestane in patients with hormone receptor-positive metastatic breast cancer 49
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials 46
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 45
Cancer management during the COVID-19 world pandemic 45
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 41
P53 antibodies as a diagnostic marker for cancer: A meta-analysis 39
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study 24
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 21
Immune-gene signature: A new tool for patient selection for checkpoint inhibitors? 21
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer 18
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study 13
The fibroblast growth factor receptors in breast cancer: From oncogenesis to better treatments 8
Totale 4.793
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.957
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020870 0 0 0 0 64 112 111 58 155 208 108 54
2020/2021900 84 157 113 65 96 60 72 50 49 78 38 38
2021/2022448 31 42 43 37 10 38 26 14 53 61 17 76
2022/2023598 58 100 77 77 50 79 4 62 51 10 21 9
2023/2024530 13 67 57 45 33 43 103 84 2 26 31 26
2024/2025506 13 123 186 95 89 0 0 0 0 0 0 0
Totale 4.793